<?xml version='1.0' encoding='UTF-8'?><xml><records><record><source-app name="HighWire" version="7.x">Drupal-HighWire</source-app><ref-type name="Journal Article">17</ref-type><contributors><authors></authors><secondary-authors><author><style face="normal" font="default" size="100%">Wang, Thomas</style></author></secondary-authors></contributors><titles><title><style face="normal" font="default" size="100%">Vitamin D and the Heart</style></title><secondary-title><style face="normal" font="default" size="100%">MD Conference Express</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2011</style></year><pub-dates><date><style  face="normal" font="default" size="100%">2011-05-01 00:00:00</style></date></pub-dates></dates><pages><style  face="normal" font="default" size="100%">32-32</style></pages><abstract><style  face="normal" font="default" size="100%">Although vitamin D supplementation appears to be a provocative intervention for reducing the risk of cardiovascular disease (CVD) and other chronic diseases, existing evidence of its benefits and risks is limited. Recruitment is now underway for the Vitamin D and Omega-3 Trial (VITAL; NCT01169259), the first large-scale, prospective, randomized clinical trial of these nutritional agents for the prevention of cancer and CVD.</style></abstract><number><style face="normal" font="default" size="100%">3</style></number><volume><style face="normal" font="default" size="100%">11</style></volume></record></records></xml>